A telomerase activation such as a treatment, Bär et al. [117], testing this phenomenon using adenovirus vector gene therapy to carry the telomerase Tert gene in a mouse model of aplastic anemia due to TS (Tert-deficient mice model) observed an increase in telomere length in peripheral blood and bone marrow cells. The gene discussed is TERT; the disease is idiopathic aplastic anemia.